Mosaic Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+2,250
New +$188K 0.13% 131
2026
Q1
Sell
-2,381
Closed -$203K 130
2025
Q4
$203K Buy
+2,381
New +$195K 0.14% 125
2024
Q3
Sell
-2,522
Closed -$233K 129
2024
Q2
$233K Buy
2,522
+70
+3% +$6.2K 0.17% 110
2024
Q1
$234K Buy
+2,452
New +$206K 0.19% 105

Other funds holding EW

Mosaic Financial Group's EW Position: Q2 2026 in Review

Mosaic Financial Group opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,250 shares worth $204K. The stake represents 0.13% of the portfolio and ranks #131 among its holdings. This is a return to the name: Mosaic Financial Group previously reported a position in EW as recently as Q4 2025.

Mosaic Financial Group first reported a position in EW in Q1 2024 and has held it in 4 quarters since. The position peaked at $234K in Q1 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mosaic Financial Group held 2,250 shares of Edwards Lifesciences worth $204K as of Q2 2026.
  • Edwards Lifesciences was a new Mosaic Financial Group position in Q2 2026.
  • Edwards Lifesciences made up 0.13% of Mosaic Financial Group's portfolio in Q2 2026, its #131 holding.
  • Mosaic Financial Group first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 4 quarters since.
  • Mosaic Financial Group's Edwards Lifesciences position peaked at $234K in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mosaic Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.